UK Regulator Cites CluePoints’ Solutions In Updated Guidance

CluePoints has been cited in the updated Good Clinical Practice (GCP) guidance from the UK’s MHRA, putting the agency´s weight behind CluePoints’ statistical monitoring solutions.

The document, Oversight and Monitoring Activities, covers a broad range of clinical trial activities, including the use of committees to manage trials or review emerging safety data, the central review of clinical trial data, data management processes, and pharmacovigilance signal detection.